Article info

Download PDFPDF

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

Authors

  1. a dobbinke{at}uga.edu
  2. b acesano{at}nanostring.com
  3. c jalvare3{at}its.jnj.com
  4. d rehawtin{at}gmail.com
  5. e sylvia{at}zellnet.com
  6. f lkirsch{at}adaptivebiotech.com
  7. g Giuseppe.Masucci{at}ki.se
  8. h paul.robbins{at}pfizer.com
  9. i senthamils59{at}gmail.com
  10. j hs30c{at}nih.gov
  11. k jzhang{at}covarisinc.com
  12. l butterfieldl{at}upmc.edu
  13. m thurinm{at}mail.nih.gov
View Full Text

Citation

Dobbin KK, Cesano A, Alvarez J, et al
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

Publication history

  • Received June 24, 2016
  • Accepted October 20, 2016
  • First published November 15, 2016.
Online issue publication 
November 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.